DelBello draws added scrutiny for undisclosed funds

University of Cincinnati researcher Melissa DelBello is getting some added scrutiny after finding herself in Senator Charles Grassley's crosshairs. Grassley (R-IA) chastised the researcher for failing to disclose large sums of money she received from AstraZeneca a year after completing a study of Seroquel for bipolar disease. Grassley also criticized AstraZeneca's undisclosed financial ties to a company DelBello formed. DelBello will now be required to review all the money she has received from AstraZeneca in the last decade and will review all her financial ties to outside companies.

- check out the report in the Cincinnati Enquirer

Suggested Articles

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.